Nasdaq Stocks

In recent trading, shares of PTC Inc (Symbol: PTC) have crossed above the average analyst 12-month target price of $100.43, changing hands for $101.14/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation,

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

In recent trading, shares of Carvana Co (Symbol: CVNA) have crossed above the average analyst 12-month target price of $233.19, changing hands for $234.30/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati

In recent trading, shares of Medpace Holdings Inc (Symbol: MEDP) have crossed above the average analyst 12-month target price of $125.00, changing hands for $126.43/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

In recent trading, shares of MercadoLibre Inc (Symbol: MELI) have crossed above the average analyst 12-month target price of $1413.64, changing hands for $1416.99/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

In recent trading, shares of Scotts Miracle-Gro Co (Symbol: SMG) have crossed above the average analyst 12-month target price of $168.75, changing hands for $169.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

In recent trading, shares of Vipshop Holdings Ltd (Symbol: VIPS) have crossed above the average analyst 12-month target price of $23.53, changing hands for $24.24/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

In recent trading, shares of Array Technologies Inc (Symbol: ARRY) have crossed above the average analyst 12-month target price of $43.92, changing hands for $45.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

In recent trading, shares of NovoCure Ltd (Symbol: NVCR) have crossed above the average analyst 12-month target price of $128.67, changing hands for $132.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua

The possible arrival of a coronavirus vaccine in the coming weeks means the Federal Reserve may soon have to lay out its plans for helping the economy navigate the potentially choppy transition to a post-pandemic world.

Euro zone business activity contracted sharply this month as renewed lockdowns forced many firms in the bloc's dominant service industry to close temporarily, although news of possible vaccines boosted hopes for 2021, surveys showed on Monday.

Euro zone business activity has contracted sharply this month as renewed restrictions to try to quell the spread of the coronavirus forced many firms in the bloc's dominant service industry to close temporarily, a survey showed on Monday.

French business activity contracted this month at the fastest pace since May as the second coronavirus lockdown this year clobbered the dominant services sector, a survey showed on Monday.

We believe that Steelcase Inc stock (NYSE: SCS) may be a decent opportunity at the present time. Steelcase is a US-based furniture company producing office furniture, architectural, and technology products for office environments, and to some extent in the education, health car

We believe that there is a sizable upside in Pioneer Natural Resources stock (NYSE: PXD) at the current price of $95 as it is down by 40% this year. It traded at a pre-Covid high of $140 in February before dropping to the lows of $56 in March. Supported by the recovery in bench

After almost a 90% rise from its March lows of this year, at the current price of $53 per share, Nucor stock (NYSE: NUE) looks slightly overvalued. The stock has rallied from $28 to $53 off its recent bottom, compared to the S&P 500 which increased 60% from its recent lows.

Illumina (NASDAQ: ILMN), best known for its genetic variation and biological function systems, trades at about 12x trailing Revenues, compared to over 19x for Intuitive Surgical (NASDAQ: ISRG), which manufactures robotic surgical platforms. Does this gap in Illumina’s val